PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 99 filers reported holding PTC THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $17,106,000 | -11.8% | 1,567,925 | +13.2% | 0.00% | -25.0% |
| Q3 2016 | $19,398,000 | +112.6% | 1,384,550 | +6.5% | 0.00% | +100.0% |
| Q2 2016 | $9,123,000 | +14.1% | 1,299,528 | +4.7% | 0.00% | 0.0% |
| Q1 2016 | $7,993,000 | -79.9% | 1,241,219 | +1.1% | 0.00% | -77.8% |
| Q4 2015 | $39,775,000 | +14.2% | 1,227,626 | -5.9% | 0.01% | 0.0% |
| Q3 2015 | $34,840,000 | -42.2% | 1,304,857 | +4.2% | 0.01% | -35.7% |
| Q2 2015 | $60,254,000 | -10.8% | 1,251,897 | +12.7% | 0.01% | -12.5% |
| Q1 2015 | $67,579,000 | +19.8% | 1,110,576 | +1.9% | 0.02% | +14.3% |
| Q4 2014 | $56,398,000 | +42.7% | 1,089,388 | +21.3% | 0.01% | +27.3% |
| Q3 2014 | $39,513,000 | +67.3% | 897,814 | -0.7% | 0.01% | +57.1% |
| Q2 2014 | $23,625,000 | +33.9% | 903,795 | +33.9% | 0.01% | +40.0% |
| Q1 2014 | $17,645,000 | +88.8% | 675,013 | +22.6% | 0.01% | +66.7% |
| Q4 2013 | $9,344,000 | +60.7% | 550,612 | +103.2% | 0.00% | +50.0% |
| Q3 2013 | $5,815,000 | – | 270,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |